Children and adults in the Netherlands with atypical hemolytic uremic syndrome (aHUS) experience differences in clinical presentation and outcomes…
Articles by Steve Bryson, PhD
Two brothers carrying identical genetic variants associated with atypical hemolytic uremic syndrome (aHUS) and hereditary thrombotic thrombocytopenic purpura…
Complement inhibitors and plasma exchange therapy are equally safe and effective for atypical hemolytic uremic syndrome (aHUS), but complement…
A rare case of atypical hemolytic uremic syndrome (aHUS) developed after a kidney transplant in a young man and…
Researchers have identified a potential gene therapy approach for atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G), two…
The safety and effectiveness of Ultomiris (ravulizumab-cwvz) as a maintenance therapy for children and adolescents with atypical hemolytic…
Leakage in an artificial heart valve appeared to trigger atypical hemolytic uremic syndrome (aHUS) in a 70-year-old woman who…
Researchers reported that atypical hemolytic uremic syndrome (aHUS) is driven by abnormal activation of the alternative complement…
Two infections — influenza followed by COVID-19 — were trigger events for separate episodes of atypical hemolytic uremic syndrome…
For this year’s aHUS Awareness Day — held annually on Sept. 24 — advocates worldwide will focus on managing the…